Warp Speed Adds Regeneron’s REGN-COV2 as the First COVID-19 Therapeutic with $450M Funding

The US government has agreed to a $450M deal to ramp up manufacturing of REGN-COV2.
$REGN $GILD $SNY $BMY $AZN $NVS #covid #warpspeed #treatment #investors #stocks https://t.co/adqmRE5lII